Prevalence of chronic kidney disease in population-based studies: Systematic review

Qiu-Li Zhang; Rothenbacher, Dietrich
January 2008
BMC Public Health;2008, Vol. 8 Issue 1, p117
Academic Journal
Background: Chronic kidney disease (CKD) is becoming a major public health problem worldwide. This article reviews the published evidence of prevalence of CKD in population-based study samples that used the standardized definition from the Kidney Disease Outcomes Quality Initiative of the National Kidney Foundation (K/DOQI) practice guideline, and particularly focus on performance of serum-creatinine based equations for GFR estimation. We provide a summary of available data about the burden of CKD in various populations. Methods: We performed a systematic review of available published data in MEDLINE. A combination of various keywords relevant to CKD was used in this research. Related data of included studies were extracted in a systematic way. Results: A total of 26 studies were included in this review. The studies were conducted in different populations, and the number of study participants ranged from 237 to 65181. The median prevalence of CKD was 7.2% in persons aged 30 years or older. In persons aged 64 years or older prevalence of CKD varied from 23.4% to 35.8%. Importantly, the prevalence of CKD strongly depended on which estimating equations were used. The Modification of Diet in Renal Disease Study (MDRD) equation was likely to be preferred in recent epidemiological studies compared to the adjusted Cockcroft-Gault (CG) equation. Conclusion: Worldwide, CKD is becoming a common disease in the general population. Accurately detecting CKD in special groups remains inadequate, particularly among elderly persons, females or other ethnic groups such as Asians.


Related Articles

  • CHRONIC KIDNEY DISEASE. Asif, Muhammad; Akram, Muhammad; Ullah, Atif // Professional Medical Journal;2013, Vol. 20 Issue 4, p506 

    Introduction: Chronic kidney disease (CKD) is defined as kidney damage or glomerular filtration rate <60ml/min/1.73m for 3 months or more, irrespective of cause. Objective: To measure glomerular filtration rate, free thyroxin, thyrotrophin in chronic kidney disease patients and to find out the...

  • Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Fang, Yifu; Ginsberg, Charles; Sugatani, Toshifumi; Monier-Faugere, Marie-Claude; Malluche, Hartmut; Hruska, Keith A // Kidney International;Jan2014, Vol. 85 Issue 1, p142 

    The chronic kidney disease-mineral and bone disorder (CKD-MBD) syndrome is an extremely important complication of kidney diseases. Here we tested whether CKD-MBD causes vascular calcification in early kidney failure by developing a mouse model of early CKD in a background of...

  • Prevalence of kidney disease in anaemia differs by GFR-estimating method: The Third National Health and Nutrition Examination Survey (1988–94). Estrella, Michelle M.; Astor, Brad C.; Köttgen, Anna; Selvin, Elizabeth; Coresh, Josef; Parekh, Rulan S. // Nephrology Dialysis Transplantation;Aug2010, Vol. 25 Issue 8, p2542 

    Background. Anaemia worsens as kidney function declines. Both conditions are associated with increased mortality. Serum cystatin C is purportedly a more sensitive marker of kidney disease and a better predictor of mortality than serum creatinine. However, studies suggest that extrarenal factors...

  • Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality. Coresh, Josef; Chowdhury Turin, Tanvir; Matsushita, Kunihiro; Yingying Sang; Ballew, Shoshana H.; Appel, Lawrence J.; Arima, Hisatomi; Chadban, Steven J.; Cirillo, Massimo; Djurdjev, Ognjenka; Green, Jamie A.; Heine, Gunnar H.; Inker, Lesley A.; Irie, Fujiko; Ishani, Areef; Ix, Joachim H.; Kovesdy, Csaba P.; Marks, Angharad; Ohkubo, Takayoshi; Shalev, Varda // JAMA: Journal of the American Medical Association;6/25/2014, Vol. 311 Issue 24, p2518 

    IMPORTANCE The established chronic kidney disease (CKD) progression end point of end-stage renal disease (ESRD) or a doubling of serum creatinine concentration (corresponding to a change in estimated glomerular filtration rate [GFR] of-57% or greater) is a late event. OBJECTIVE To characterize...

  • Uremic memory: the role of acute kidney injury in long-term outcomes. Golestaneh, Ladan; Melamed, Michal L.; Hostetter, Thomas H. // Kidney International;Oct2009, Vol. 76 Issue 8, p813 

    Most epidemiologic data, thus far, have focused on short-term outcomes of acute kidney injury (AKI). Lo et al. correlate AKI with long-term outcomes. The concept of ‘uremic memory’ sheds light on the importance of AKI and its permanent imprint. The focus of research should be on...

  • Health related quality of life in patients with chronic kidney disease without dialysis or transplant: a random sample from two insurance companies. Medellín, Colombia, 2008. Delgado, C. E. Yepes; Jaramillo, M. Montoya; Orozco, B. E. Orrego; Santaella, M. H. Cuéllar; J. Yepes Núñez; Muñoz, J. P. López; Bermonth, M. V. Salguero; Arias, R. D. Gómez // Nefrologia;Dec2009, Vol. 29 Issue 6, p548 

    Objective: To estimate the health related quality of life in patients with chronic kidney disease without dialysis or transplant and your association with risk factors. Design: It was a descriptive transversal study from a representative sample belongs to two Health Insurance Organizations. We...

  • Chronic kidney disease prevalence and secular trends in a UK population: the impact of MDRD and CKD-EPI formulae. Gifford, F.J.; Methven, S.; Boag, D.E.; Spalding, E.M.; MacGregor, M.S. // QJM: An International Journal of Medicine;Dec2011, Vol. 104 Issue 12, p1045 

    Introduction: Most UK laboratories use the MDRD4 formula to estimate glomerular filtration rate (eGFR), but this may exaggerate chronic kidney disease (CKD) prevalence. In a large adult population, we examined the impact of the more accurate CKD-EPI formulae on prevalence estimates, and on...

  • Decline in glomerular filtration rate during pre-dialysis phase and survival on chronic renal replacement therapy. Haapio, Mikko; Helve, Jaakko; Kurimo, Pia; Forslund, Terje; Grönhagen-Riska, Carola; Finne, Patrik // Nephrology Dialysis Transplantation;Mar2012, Vol. 27 Issue 3, p1157 

    Background. Estimated glomerular filtration rate (eGFR) is widely used in follow-up and assessment of patients before start of chronic renal replacement therapy (RRT). Reported data on impact of eGFR decline pattern during pre-dialysis phase on consequent survival on RRT are, however,...

  • Tumor-associated trypsin inhibitor (TATI) and renal function. Tramonti, Gianfranco; Ferdeghini, Marco; Donadio, Carlo; Annichiarico, Carmela; Norpoth, Maria; Bianchi, Romano; Bianchi, Claudio // Kidney International Supplement;Dec1997, Issue 63, pS179 

    Tumor-associated trypsin inhibitor (TATI) is a low molecular weight protein employed as tumor marker. To evaluate the role of the kidney in the clearance of TATI we studied the relationship of serum TATI with the glomerular filtration rate (GFR), and for comparison the relationships of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics